rifampicin 150mg capsules
viatris uk healthcare ltd - rifampicin - oral capsule - 150mg
rifampicin 150mg capsules
kent pharma (uk) ltd - rifampicin - oral capsule - 150mg
rifampicin 150mg capsules
alliance healthcare (distribution) ltd - rifampicin - oral capsule - 150mg
rifadin 600mg powder and solvent for solution for infusion vials
sanofi - rifampicin - powder and solvent for solution for infusion - 600mg
rifampicin 150mg capsules
de pharmaceuticals - rifampicin - oral capsule - 150mg
rifampicin 300mg capsules
sigma pharmaceuticals plc - rifampicin - oral capsule - 300mg
rifampicin 300mg capsules
sigma pharmaceuticals plc - rifampicin - oral capsule - 300mg
rifampicin 150mg capsules
waymade healthcare plc - rifampicin - oral capsule - 150mg
rifampicin 300mg capsules
de pharmaceuticals - rifampicin - oral capsule - 300mg
priftin- rifapentine tablet, film coated
sanofi-aventis u.s. llc - rifapentine (unii: xjm390a33u) (rifapentine - unii:xjm390a33u) - rifapentine 150 mg - priftin® (rifapentine) is indicated in adults and children 12 years and older for the treatment of active pulmonary tuberculosis (tb) caused by mycobacterium tuberculosis . priftin must always be used in combination with one or more antituberculosis (anti-tb) drugs to which the isolate is susceptible [see dosage and administration (2.1) and clinical studies (14.1)]. limitations of use do not use priftin monotherapy in either the initial or the continuation phases of active antituberculous treatment. priftin should not be used once weekly in the continuation phase regimen in combination with isoniazid (inh) in hiv-infected patients with active pulmonary tuberculosis because of a higher rate of failure and/or relapse with rifampin (rif)-resistant organisms [see warnings and precautions (5.4) and clinical studies (14.1)]. priftin has not been studied as part of the initial phase treatment regimen in hiv-infected patients with active pulmonary tuberculosis. priftin is indicated in adults and children 2 years an